The MEINOX has developed its in-company IP strategy to ensure the protection of her proprietary MEISi-EX™ technology. Other patent applications for the MEISi-EX™ technology are pending. In addition to these applications, Meinox will continue to investigate her Freedom to Operate and file patents protecting new developments, indications and products.
- National Patent: 2016/16602, "A COMBINATION INHIBITING MEIS PROTEINS".
- PCT 25418.57, PCT/TR2017/050445 "A COMBINATION INHIBITING MEIS PROTEINS".
- WO2018203855A2 /EP3541410A2 / US20190343886A1 / AU2017412642A1 / CN109963580A / KR20190084953A / JP2020500185A